Management of Coagulopathy in Liver Disease

Gastroenterology & Hepatology May 2014, Volume 10, Issue 5 Stephen H. Caldwell, MD, Professor of Medicine, Department of Medicine, Division of Gastroenterology and Hepatology, University of Virginia School of Medicine, Charlottesville, […]

NASH in Special Populations

Gastroenterology & Hepatology April 2014, Volume 10, Issue 4 Ayako Suzuki, MD, PhD, MSc Associate Professor, Division of Gastroenterology and Hepatology, University of Arkansas Medical School, Director of Hepatology, Central Arkansas […]

Advances in the Diagnosis and Treatment of Nonalcoholic Steatohepatitis

Gastroenterology & Hepatology March 2014, Volume 10, Issue 3 Kris V. Kowdley, MD Director, Liver Center of Excellence, Digestive Disease Institute at Virginia Mason Medical Center, Clinical Professor […]

Early Detection of Hepatocellular Carcinoma Through Surveillance Using Biomarkers

Gastroenterology & Hepatology February 2014, Volume 10, Issue 2 Early Detection of Hepatocellular Carcinoma Through Surveillance Using Biomarkers Robert G. Gish, MD, Robert G. Gish Consultants, […]

Fibrosis and Cirrhosis in HCV Infection

Gastroenterology and Hepatology January 2014, Volume 10, Issue 1 Fibrosis and Cirrhosis in HCV Infection Mitchell L. Shiffman, MD, Director, Liver Institute of Virginia, Bon Secours Health System, Richmond […]

Acute Renal Dysfunction in Liver Cirrhosis

Acute Renal Dysfunction in Liver Cirrhosis Florence Wong, MBBS, MD, FRACP, FRCPC, Professor of Medicine, Department of Medicine, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada G&H How common is […]

Reversibility of Liver Fibrosis

Reversibility of Liver Fibrosis David A. Brenner, MD, Vice Chancellor for Health Sciences, Dean of the School of Medicine, University of California, San Diego, San Diego, California G&H What causes […]

Discontinuation of Nucleoside Analogs in Hepatitis B Virus Infection

Pietro Lampertico MD, PhD Assistant Professor 1st Division of Gastroenterology Fondazione IRCCS Ca’ Granda – Ospedale Maggiore Policlinico Università degli Studi di Milano Milan, Italy G&H […]

Delta Virus Infection: Epidemiology and Initiatives to Intercept It

Robert Gish, MD Medical Director, Clinical Hepatology The University of California, San Diego San Diego, California G&H How prevalent is hepatitis D virus, and does it […]

Use of Statins in Hepatocellular Carcinoma

Abby B. Siegel, MD, MS Assistant Professor of Medicine Columbia University College of Physicians and Surgeons New York, New York G&H What prompted study of statin […]

Diagnosis, Prognosis, and Management of Primary Sclerosing Cholangitis

Cyriel Ponsioen, MD, PhD Gastroenterologist and Clinical Research Investigator Department of Gastroenterology and Hepatology Academic Medical Center Amsterdam, The Netherlands G&H What underlies the symptoms of […]

Protease Inhibitor Therapy Post–Liver Transplantation in the Treatment of Hepatitis C Virus Infection

Satheesh P. Nair, MD Professor of Medicine Director of Transplant Hepatology University of Tennessee Health Science Center Memphis, Tennessee G&H What is the current consensus regarding […]

Management of Anemia in Patients Receiving Triple Therapy for Hepatitis C

A. Sidney Barritt IV, MD, MSCR Assistant Professor of Medicine University of North Carolina at Chapel Hill Chapel Hill, North Carolina G&H What effect does treatment-related […]

Liver Complications in Patients with Congestive Heart Failure

Cosmas C. Giallourakis, MD Assistant Professor of Medicine Gastroenterology Unit Department of Medicine Massachusetts General Hospital Boston, Massachusetts G&H What are the underlying causes of comorbid […]

Epidemiologic Concerns and Advances in Knowledge on Hepatitis E

Rakesh Aggarwal, MD, DM Professor Department of Gastroenterology Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow, India G&H What is the potential epidemiologic impact of hepatitis […]

Early Recognition of Alpha-1 Antitrypsin Deficiency and Considerations for Liver Transplantation

Advances in Hepatology Early Recognition of Alpha-1 Antitrypsin Deficiency and Considerations for Liver Transplantation Andreas Tzakis, MD, PhD Director Transplant Center Cleveland Clinic Florida Weston, Florida […]

Management of Anorectal Symptoms Associated with Telaprevir

Paul J. Pockros, MD Director of the Liver Disease Center Division of Gastroenterology and Hepatology Scripps Clinic La Jolla, California G&H How frequently do telaprevir-treated patients […]

Therapies for Nonalcoholic Steatohepatitis

Suzanne Mahady, MD, MMed (Clinical Epidemiology) Gastroenterologist and Lecturer Sydney School of Public Health The University of Sydney Sydney, Australia G&H Which types of therapies have […]

Could Vitamin D Supplementation Benefit Patients with Chronic Liver Disease?

G&H Do vitamin D levels affect the progression of fibrosis or the development of cirrhosis in patients with chronic liver disease? IB In a recent study, […]

Protease Inhibitor–Based Therapy for Hepatitis C Virus Infection—Why Wait?

Joseph S. Galati, MD Medical Director Center of Liver Disease and Transplantation The Methodist Hospital Houston, Texas G&H How did the advent of boceprevir (Victrelis, Merck) […]